Superworth

Biotech stocks with the highest free cash flow yield

Free cash flow over the last twelve months as a share of market value. As of .

Ranked
17
of 146 biotech stocks we cover
Median
3.7%
Highest
17.7%
BCRX
Range
1.1% to 17.7%
median 3.7%
1.1%17.7%
#CompanyFCF yieldPERevenue growth (TTM)Market cap
1BCRXBiocryst Pharmaceuticals17.7%n/m+68.7%$2.1B
2INCYIncyte7.9%15.3×+26.9%$24.3B
3EXELExelixis6.7%22.1×+9.2%$17.4B
4NBIXNeurocrine Biosciences5.9%21.3×+34.4%$14.8B
5HALOHalozyme Therapeutics5.5%38.5×+41.2%$14.6B
6ADMAAdma Biologics4.7%15.8×+8.0%$2.5B
7UTHRUnited Therapeutics4.2%21.6×+2.5%$25.9B
8REGNRegeneron Pharmaceuticals3.8%24.0×+9.3%$100B
9ALNYAlnylam Pharmaceuticals3.7%26.7×+95.1%$21.2B
10PLXProtalix BioTherapeutics3.7%11.1×+30.1%$206.3M
11ONCBeOne Medicines3.3%63.2×+34.3%$40.2B
12VCELVericel3.0%88.1×+23.0%$2.1B
13KRYSKrystal Biotech2.9%37.1×+22.6%$8.8B
14TECHBIO-TECHNE2.3%63.2×−0.4%$11.4B
15TARSTarsus Pharmaceuticals1.7%n/m+105.2%$3.2B
16MGTXMeiraGTx1.2%13.1×n/m$895.1M
17RGENRepligen1.1%237×+16.5%$9.8B

Not ranked: 76 with no positive free cash flow, 29 with not a meaningful number. 24 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

FCF yield for other groups

Other rankings of biotech stocks

The group